JEFFREY ADELGLASS, M.D., F.A.C.S.
CLINICAL RESEARCH STUDIES
Dallas | ft. worth TEXAS
currently enrolling subjects for
PAID CLINICAL RESEARCH participation
What is the HUMMINGBIRD Study?
The HUMMINGBIRD study is testing an investigational vaccine that is designed to prevent coronavirus disease
2019 (COVID-19). The study vaccine is a protein-based (or traditional) vaccine and is not an mRNA vaccine.
NVX-CoV2373 has been authorized in various countries for adolescents and adults 12 years of age and older.
Now, researchers are evaluating it for children ages 6 months to 11 years.
To be eligible for this study, your child must:
• Be 6 months to 11 years of age
• Have never been diagnosed with COVID-19
• Not have received a previous vaccine to protect against COVID-19
This is not a complete list of eligibility criteria. The study doctor
will review the full entry criteria for this study with you.
Call (972) 746-2222 Now to Find Out if Your Child Qualifies for this Study
Are You Looking for an Adult COVID-19 Vaccine Study? Visit that Page Here.
Call 972-746-2222 Now to Schedule